Awardee: Silvia Martin Almedina
Institution: St. George’s University of London
Awarded: $25,000
Funding Period: September 1, 2022 - August 31, 2023
Molecular mechanisms of EPHB4 pathogenesis – towards new treatment development for lymphatic anomalies
Previous
Previous
Multi-organ Gene Therapy for Bloom Syndrome
Next
Next